Drug Recall: Cold Relief Tablets Due to cGMP Deviations
Ultra Seal Corporation is voluntarily recalling Cold Relief tablets nationwide due to current Good Manufacturing Practice (cGMP) deviations. The affected product is distributed nationwide in the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving cGMP deviations, a manufacturing process deviation rather than a direct hazard to consumers. No illnesses or injuries are reported in the source text, and the hazard is related to manufacturing compliance rather than product contamination or structural defect.
Plain-English summary
Ultra Seal Corporation is voluntarily recalling Cold Relief (acetaminophen 250 mg, guaifenesin 200 mg, phenylephrine HCl 5 mg), sold as 2 tablets per packet and manufactured for First Aid Direct in Mason, Ohio. The recall affects 7,858,690 packets distributed nationwide within the United States.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations identified during manufacturing. The affected lots include: K9456, AK9454, 9456, AK9456 (Exp. 01/2022); AK9524, AK9528 (Exp. 03/2022); K9767, AK9767 (Exp. 08/2022); AK9824, AK9823 (Exp. 09/2022); and AK9564 (Exp. 04/2022).
Consumers who have this product should stop using it. Those with questions about the recall should contact Ultra Seal Corporation or their healthcare provider. The recall was initiated on January 24, 2022, and was terminated on October 16, 2023.
The recalled product
- Product
- Cold Relief (acetaminophen 250 mg, guaifenesin 200mg, phenylephrine HCl 5 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040, NDC 42961-112-03
- Manufacturer
- Ultra Seal Corporation
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: K9456
- AK9454
- 9456
- AK9456
- Exp. Date 01/2022
- AK9524
- AK9528 Exp. Date 03/2022
- K9767
- AK9767
- Exp. Date 08/2022
- AK9824
- AK9823
- Exp. Date 09/2022
- AK9564
- Exp. Date 04/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27